Oct 29 (Reuters) - iRhythm Technologies Inc ::ON OCTOBER 23, ENTERED THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT.AGREEMENT PROVIDES FOR A $35 MILLION TERM LOAN FACILITY.AGREEMENT ALSO PROVIDES FOR $25 MILLION REVOLVING LINE CREDIT FACILITY.PROCEEDS OF TERM LOAN FACILITY WERE USED, WITH CASH ON HAND, TO REPAY ALL AMOUNTS OWING UNDER LOAN AGREEMENT DATED DEC 4, 2015.STATED MATURITY DATE OF TERM LOAN FACILITY IS OCTOBER 1, 2023.ON OCTOBER 24, 2018, COMPANY TERMINATED PHARMAKON LOAN AGREEMENT IN ADVANCE OF ITS MATURITY DATE.
Full Article
Aug 1 (Reuters) - iRhythm Technologies Inc ::IRHYTHM TECHNOLOGIES ANNOUNCES SECOND QUARTER FINANCIAL RESULTS.Q2 REVENUE $35.5 MILLION VERSUS I/B/E/S VIEW $32.5 MILLION.SEES FY 2018 REVENUE $138 MILLION TO $141 MILLION.SEES FY 2018 REVENUE UP 45 TO 48 PERCENT.QTRLY LOSS PER SHARE $0.51.
Full Article
Nov 1 (Reuters) - iRhythm Technologies Inc :iRhythm Technologies Inc announces third quarter 2017 financial results and raises guidance for full year 2017.Q3 revenue $25 million versus I/B/E/S view $23.9 million.Sees fy 2017 revenue $96 million to $97 million.iRhythm Technologies Inc sees gross margins for full year 2017 to range from 71.5% to 72.5%.iRhythm Technologies Inc - qtrly loss earnings per share , basic and diluted $0.29.
Full Article
Irhythm Technologies Inc : Irhythm Technologies announces fourth quarter and 2016 financial results and provides full year 2017 financial outlook . Q4 revenue $18.7 million versus I/B/E/S view $17.3 million . Sees FY 2017 revenue $85 million to $90 million . Sees gross margins for full year 2017 to range from 69 pct to 71 pct . FY2017 revenue view $85.0 million -- Thomson Reuters I/B/E/S . Qtrly loss per share $0.37 .Q4 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S.
Full Article
Earnings vs. 
Estimates